ALCAM 靶点蛋白|抗体药物|临床药物信息

ALCAM信息

英文名称：Activated leukocyte cell adhesion molecule
中文名称：活化白细胞粘附分子
靶点别称：CD166 antigen，Activated leukocyte cell adhesion molecule，CD166，ALCAM，MEMD，Activated Leucocyte Cell Adhesion Molecule，Activated-Leukocyte Cell Adhesion Molecule

上市药物数量：0
临床药物数量：1
最高研发阶段：临床二期

ALCAM产品列表

筛选结果

产品库

在线 (2)

物种

Human (2)

标签

属性

Protein (2)

标记

Unconjugated (2)

货号	物种	产品描述	蛋白结构	纯度	活性
CD6-H5228	Human	Human ALCAM Protein, His Tag
CD6-H5259	Human	Human CD166 /ALCAM Protein, with C-Fc Tag

ALCAM 分子别名

CD166,ALCAM,CD6L,KG-CAM,MEMD

ALCAM 分子背景

CD166 antigen is a 100-105 kD typeI transmembrane glycoprotein that is a member of the immunoglobulin superfamily of proteins, which is also known as Activated leukocyte cell adhesion molecule (ALCAM) in human, SC-1/DM-GRASP/BEN in the chicken, and KG-CAM in the rat. CD166 is a cell adhesion molecule that binds to CD6. CD166 involved in neurite extension by neurons via heterophilic and homophilic interactions.

ALCAM 前沿进展

ALCAM临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
Praluzatamab ravtansine	CX-2009	临床二期	Immunogen Inc, Cytomx Therapeutics Inc	实体瘤, 卵巢癌, 头颈癌, 三阴性乳腺癌, 肿瘤, 乳腺癌, 非小细胞肺癌	详情

会议日历

会议一览

ALCAM